What is Acetyl Hexapeptide-8 (Argireline)?
Acetyl Hexapeptide-8, marketed under the trade name Argireline (registered by Lipotec), is a six-amino-acid synthetic peptide that mimics the N-terminal fragment of SNAP-25, a protein involved in muscle contraction. By binding competitively to the SNARE complex, it reduces nerve-to-muscle signaling in superficial expression-line muscles — producing a smoothing effect on wrinkles caused by repetitive expression (forehead lines, crow's feet). It is sometimes called "topical botox" in marketing, though the mechanism and magnitude differ substantially from botulinum toxin. Argireline has been in commercial use since 2002 and has extensive published clinical data. CALLA produces Argireline serums, eye creams, and patches at concentrations from 5% to 10%.
How It Works
Argireline competes with the natural SNAP-25 protein at the SNARE complex, partially blocking the docking of acetylcholine vesicles required for muscle contraction signal transmission. Topically, this affects only superficial facial muscles. Clinical studies at 10% concentration show ~17% reduction in periocular wrinkle depth at 30 days. Effects are temporary and require continuous use. Best results when applied twice daily to expression-line areas.
Market Context for Brand Owners
Argireline is the most-recognized name in the consumer "anti-wrinkle" peptide category. Strong demand in Asian markets (Korea, China, Japan), GCC, and increasingly in LatAm. Consumer-facing prices: USD 15-60 for 30ml serums, USD 25-80 for eye creams. The ingredient supports a clear claim ("reduces expression lines") that resonates with consumers age 30-55, making it a reliable hero ingredient for anti-aging product lines.
Formulation & Manufacturing Notes
Stable in aqueous formulations at pH 5.0-7.0. Compatible with hyaluronic acid, niacinamide, panthenol, and other peptides. Avoid combining with strong acids (AHA, BHA) at high concentrations as they can degrade the peptide bonds. Effective concentrations: 5% (entry-level), 8% (standard), 10% (premium claim). Pairs especially well in eye creams with caffeine, peptide complexes, and HA. Soluble in water; encapsulation can extend stability and penetration.
Regulatory Status
Acetyl Hexapeptide-8 is approved as a cosmetic ingredient in all major markets without concentration limits: FDA (US), CPSR (EU/UK), CFDA, KFDA, TGA, ANVISA, COFEPRIS, INVIMA. Cannot be marketed with medical claims (e.g., "treats wrinkles"); cosmetic claims ("reduces appearance of wrinkles") are permitted in all jurisdictions.
